Familial monoclonal gammopathy: Hyper-responsive B cells in unaffected family members

European Journal of Haematology

Volumn 86, Issue 5, 2011, Pages 396-404

  Steingrimsdottir, Hli F ^a,b   Einarsdóttir, Helga K ^b   Haraldsdóttir, Vilhelmína ^a   Ögmundsdóttir, Helga M ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Familial; Monoclonal gammopathy; Monoclonal gammopathy of undetermined significance; Multiple myeloma; Waldenstr ms macroglobulinemia

Indexed keywords

CD27 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARAPROTEIN; POKEWEED MITOGEN;

ADULT; ARTICLE; B LYMPHOCYTE; CANCER REGISTRY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL DISEASE; FLOW CYTOMETRY; GENETIC PREDISPOSITION; HUMAN; ICELAND; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE CULTURE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MEMORY CELL; MONOCLONAL IMMUNOGLOBULINEMIA; PEDIGREE; PLASMA CELL; PREVALENCE; PRIORITY JOURNAL; RELATIVE; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; B-LYMPHOCYTES; CASE-CONTROL STUDIES; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ICELAND; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIPLE MYELOMA; PARAPROTEINEMIAS; PARAPROTEINS; PEDIGREE; REGISTRIES; WALDENSTROM MACROGLOBULINEMIA; YOUNG ADULT;

EID: 79954419329     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2011.01593.x     Document Type: Article

References (41)

1. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ 3rd. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25years later. Mayo Clin Proc 2004;79:859-66.
2. Ogmundsdottir HM, Haraldsdottir V, M Jóhannesson G, Olafsdottir G, Bjarnadottir K, Sigvaldason H, Tulinius H. Monoclonal gammopathy in Iceland: a population-based registry and follow-up. Br J Haematol 2002;118:166-73.
3. Steingrimsdottir H, Haraldsdottir V, Olafsson I, Gudnason V, Ogmundsdottir HM. Monoclonal gammopathy: natural history studied with a retrospective approach. Haematologica 2007;92:1131-4.
4. Axelsson U, Bachmann R, Hallen J. Frequency of pathological proteins (M-components) om 6, 995 sera from an adult population. Acta Med Scand 1966;179:235-47.
5. Baris D, Silverman DT, Brown LM, et al. Occupation, pesticide exposure and risk of multiple myeloma. Scand J Work Environ Health 2004;30:215-22.
6. Pahwa P, McDuffie HH, Dosman JA, Robson D, McLaughlin JR, Spinelli JJ, Fincham S. Exposure to animals and selected risk factors among Canadian farm residents with Hodgkin's disease, multiple myeloma, or soft tissue sarcoma. J Occup Environ Med 2003;45:857-68.
7. Brown LM, Burmeister LF, Everett GD, Blair A. Pesticide exposures and multiple myeloma in Iowa men. Cancer Causes Control 1993;4:153-6.
8. Landgren O, Linet MS, McMaster ML, Gridley G, Hemminki K, Goldin LR. Familial characteristics of autoimmune and hematologic disorders in 8, 406 multiple myeloma patients: a population-based case-control study. Int J Cancer 2006;118:3095-8.
9. Eriksson M. Rheumatoid arthritis as a risk factor for multiple myeloma: a case-control study. Eur J Cancer 1993;29A:259-63.
10. Isomaki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 1978;31:691-6.
11. Morgan GJ, Davies FE, Linet M. Myeloma aetiology and epidemiology. Biomed Pharmacother 2002;56:223-34.
12. Landgren O, Gridley G, Turesson I, Caporaso NE, Goldin LR, Baris D, Fears TR, Hoover RN, Linet MS. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 2006;107:904-6.
13. Landgren O, Katzmann JA, Hsing AW, et al. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc 2007;82:1468-73.
14. Roddie PH, Dang R, Parker AC. Multiple myeloma in three siblings. Clin Lab Haematol 1998;20:191-3.
15. Zawadzki ZA, Aizawa Y, Kraj MA, Haradin AR, Fisher B. Familial immunopathies: report of nine families and survey of literature. Cancer 1977;40:2094-101.
16. Youinou P, le Goff P, Saleun JP, Rivat L, Morin JF, Fauchier C, le Menn G. Familial occurrence of monoclonal gammapathies. Biomedicine 1978;28:226-32.
17. Renier G, Ifrah N, Chevailler A, Saint-Andre JP, Boasson M, Hurez D. Four brothers with Waldenstrom's macroglobulinemia. Cancer 1989;64:1554-9.
18. McMaster ML. Familial Waldenstrom's macroglobulinemia. Semin Oncol 2003;30:146-52.
19. Treon SP, Hunter ZR, Aggarwal A, et al. Characterization of familial Waldenstrom's macroglobulinemia. Ann Oncol 2006;17:488-94.
20. Fraumeni JF, Wertelecki W, Blattner WA, Jensen RD, Leventhal BG. Varied manifestations of a familial lymphoproliferative disorder. Am J Med 1975;59:145-51.
21. Boga M, Jako J, Doman J, Magyar E, Konyar E. Familial myeloma. Folia Haematol Int Mag Klin Morphol Blutforsch 1973;100:201-12.
22. Brown AK, Elves MW, Gunson HH, Pell-Ilderton R. Waldenstroms macroglobulinaemia. A family study. Acta Haematol 1967;38:184-92.
23. Fine JM, Marneux M. [Recent data on monoclonal gammopathies]. Rev Fr Transfus Immunohematol 1985;28:591-600.
24. Getaz EP, Staples WG. Familial Waldenstrom's macroglobulinaemia: a case report. S Afr Med J 1977;51:891-2.
25. Kalff MW, Hijmans W. Family studies in Waldenstrom's macroglobulinaemia. Ned Tijdschr Geneeskd 1966;110:1932-3.
26. Linet MS, Humphrey RL, Mehl ES, Brown LM, Pottern LM, Bias WB, McCaffrey L. A case-control and family study of Waldenstrom's macroglobulinemia. Leukemia 1993;7:1363-9.
27. Taleb N, Tohme A, Abi Jirgiss D, Kattan J, Salloum E. Familial macroglobulinemia in a Lebanese family with two sisters presenting Waldenstrom's disease. Acta Oncol 1991;30:703-5.
28. Bjornsson OG, Arnason A, Gudmunosson S, Jensson O, Olafsson S, Valimarsson H. Macroglobulinaemia in an Icelandic family. Acta Med Scand 1978;203:283-8.
29. Landgren O, Kristinsson SY, Goldin LR, et al. Risk of plasma-cell and lymphoproliferative disorders among 14, 621 first-degree relatives of 4, 458 patients with monoclonal gammopathy of undetermined significance (MGUS) in Sweden. Blood 2009;113:6263-4.
30. Kristinsson SY, Bjorkholm M, Goldin LR, McMaster ML, Turesson I, Landgren O. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden. Blood 2008;112:3052-6.
31. Ogmundsdottir HM, Einarsdottir HK, Steingrimsdottir H, Haraldsdottir V. Familial predisposition to monoclonal gammopathy of unknown significance, Waldenstrom's macroglobulinemia, and multiple myeloma. Clin Lymphoma Myeloma 2009;9:27-9.
32. Ogmundsdottir HM, Haraldsdottirm V, Johannesson GM, Olafsdottir G, Bjarnadottir K, Sigvaldason H, Tulinius H. Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families. Haematologica 2005;90:66-71.
33. Ogmundsdottir HM, Johannesson GM, Sveinsdottir S, Einarsdottir S, Hegeman A, Jensson O. Familial macroglobulinaemia: hyperactive B-cells but normal natural killer function. Scand J Immunol 1994;40:195-200.
34. Ogmundsdottir HM, Sveinsdottir S, Sigfusson A, Skaftadottir I, Jonasson JG, Agnarsson BA. Enhanced B cell survival in familial macroglobulinaemia is associated with increased expression of Bcl-2. Clin Exp Immunol 1999;117:252-60.
35. McMaster ML, Csako G, Giambarresi TR, Vasquez L, Berg M, Saddlemire S, Hulley B, Tucker MA. Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia families. Clin Cancer Res 2007;13:5063-9.
36. Hasler G, Drevets WC, Gould TD, Gottesman II, Manji HK. Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatr 2006;60:93-105.
37. Jeppson JO, Laurell CB, Franzen B. Agarose gel electrophoresis. Clin Chem 1979;25:629-38.
38. Ritchie RF, Smith R. Immunofixation. I. General principles and application to agarose gel electrophoresis. Clin Chem 1976;22:497-9.
39. Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, Drew R. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001;47:673-80.
40. Vachon CM, Kyle RA, Therneau TM, et al. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood 2009;114:785-90.
41. McMaster ML, Caporaso N. Waldenstrom macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition. Br J Haematol 2007;139:663-71.